IMAX’s new theatre deals in India and the US

IMAX (IMAX) has announced two new IMAX with Laser partnerships, three locations with Asian Cinemas in India and five with Georgia Theatre Company in the southeastern US, expanding its premium large format footprint.

These theatre deals come as IMAX’s share price shows mixed short term trading and stronger recent momentum, with a 30 day share price return of 13.63% and a 1 year total shareholder return of 46.55%.

If this kind of growth story catches your eye, it could be a good moment to scan the wider market and look for 20 top founder-led companies

With IMAX stock up 13.6% over the past month and 46.5% over the past year, plus an indicated 18.9% intrinsic discount, is the recent deal momentum a genuine opening, or is the market already pricing in future growth?

Most Popular Narrative: 14.3% Undervalued

IMAX last closed at $40.11, while the most widely followed narrative points to a fair value of $46.82, anchored on stronger earnings power and margins.

Diversification of content offerings including local language blockbusters, alternative content (concerts, live events), and deeper relationships with streaming and tech partners like Apple, Amazon, and Netflix is broadening IMAX's audience base and improving margin mix, contributing to higher contribution per screen and more resilient earnings.

Want to see what underpins that higher fair value? The narrative leans heavily on accelerating earnings, thicker margins, and a future profit multiple that assumes IMAX’s cash generation looks very different from today.

Result: Fair Value of $46.82 (UNDERVALUED)

However, this depends on cinema attendance and blockbuster output holding up. At the same time, high capital needs for new systems and upgrades could pressure margins if growth expectations slip.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another View: Rich Earnings Multiple Raises the Bar

The SWS DCF model suggests IMAX is trading about 18.9% below an estimated future cash flow value of $49.47, which lines up with the 14.3% discount to the $46.82 fair value narrative. If cash flows do not evolve as forecast, how much room is left in that upside story?

Next Steps

With both risks and rewards on the table, does the story feel balanced enough for you? Act while the details are fresh and weigh up the 3 key rewards and 2 important warning signs.

Looking for more investment ideas?

Before moving on, give yourself a few minutes to scan other opportunities so you are not relying on a single stock story when the market shifts.

• Spot potential value in companies that combine quality and attractive pricing by checking out 46 high quality undervalued stocks.
• Strengthen your income stream by focusing on reliable payers inside the 9 dividend fortresses.
• Dial down portfolio stress by hunting for companies screened as 63 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.